Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cambridge Antibody Technology Group -- Ignore unavailable to you. Want to Upgrade?

To: paradigm7241 who wrote (65)	2/21/2000 8:29:00 AM
From: Jongmans	Read Replies (1) \| Respond to of 625

MorpoSys is at Euro 330 now. However, due to the somewhat difficult presentation of the number of shares, I think there is a miscalculation in your number of outstanding shares. After a carefull look, I come to the conclusion that, at the end of the third quarter 1999, the number of outstanding shares was 3.486.469 shares (see 9 months"statement at morphosys.com. ). There is a possibility, that after this announcement, Bayer has taken a participation, as part of an upfront payment!? On this base the marketcapitalisation would be now: Euro 1.15053090, or US 1.133bln. Still much too high if compared to CAT, but less extreme. Am I right? Martin